Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep TX...saw that...won't hurt them unless they don't file at all...which won't happen.
bought more BOL, IRIS, EZM and NCOC. eom
I'll be out in the morning....looking for lower than $3 maybe...trend just leaning that way.
WSTL - Westell Technologies Reports 4th Quarter and Fiscal 2006 Results
May 11, 2006 16:01:01 (ET)
AURORA, Ill., May 11, 2006 (BUSINESS WIRE) -- Westell Technologies, Inc. (WSTL, Trade), a leading provider of broadband access solutions and conferencing services, today announced the results for its fourth quarter and fiscal year 2006, ending March 31, 2006.
Total revenues for the March 2006 quarter increased 7.2% to $73.1 million from $68.1 million in the December 2005 quarter. Breaking down revenues by product line for the March quarter compared to the December quarter showed Customer Networking Equipment revenue increased 1.0% to $49.1 million from $48.6 million; Conferencing Services revenue increased 10.6 % to $11.5 million from $10.4 million; Network Service Access equipment revenue increased 36.3 % to $12.4 million from $9.1 million, primarily due to the December 2005 acquisition of HyperEdge Corporation.
Compared to the fourth quarter of fiscal 2005, total revenues for the quarter decreased 6.6% to $73.1 million from $78.2 million. Customer Networking Equipment revenue decreased 15.0% to $49.1 million from $57.8 million. This decline is primarily due to the movement of customer promotional activity away from the Company's VersaLink(TM) gateway product to the ProLine(TM) modem product that carries a lower selling price. Conferencing Services revenue was flat at $11.5 million when compared to the comparable prior of the year quarter. Network Service Access revenue increased 38.1% to $12.4 million from $9.0 million primarily due to the December 2005 acquisition of HyperEdge.
Total revenues for fiscal year 2006 increased 5% to $283.2 million from $270.3 million for fiscal 2005. Customer Networking Equipment revenue increased 6% to $194.8 million from $183.4 million in fiscal 2005. Conferencing Service revenue increased 2% to $45.1 million from $44.4 million in the prior year. Revenue from the Network Services Access business increased 2% to $43.3 million from $42.5 million in fiscal 2005.
Westell reported net income for the fourth quarter of $2.5 million, or $0.04 per diluted share, which includes an income tax expense of $3.2 million. As part of this tax expense the Company recorded an additional valuation allowance in the amount of $785 thousand, primarily related to state net operating loss carryforwards that the Company no longer believes will be utilized. Net income for fiscal 2006 was $12.8 million, or $0.18 per diluted share, including an income tax expense of $10.1 million. During the fourth quarter of last year, the Company recorded net income of $28.4 million, or $0.40 per diluted share including a tax benefit of $20.1 million, resulting from the release of a deferred tax valuation allowance. For fiscal 2005, net income was $39.7 million or $0.56 per diluted share that included a tax benefit of $12.8 million, resulting from the release of a deferred tax valuation allowance.
"Westell generated cash from operating activities of over $32 million for the fiscal year," said Nicholas Hindman, Westell Senior Vice President and CFO. "Our balance sheet continued to improve and we remain in a near debt-free position. Our financial strength provides Westell with the flexibility to take advantage of any strategic partnering and acquisition opportunities should they arise. A good example of this flexibility was our $14 million cash acquisition of HyperEdge Corporation in December 2005," Hindman said.
"As we outlined at this time last year, we expected increased market activity in the areas of VoIP, Video/IPTV and wired-wireless convergence and that has occurred. We did not expect meaningful deployments in fiscal 2006; however, we continue to participate in market trials in all of these areas, including some trials internationally. These markets remain opportunities in our future," said Cullens, Westell President and CEO.
Outlook
"In Fiscal 2007 we expect to see continuing increases in market activity in the areas of VoIP, Video/IPTV, in-premise networking, wireline-wireless convergence (FMC/IMS) and multi-functional broadband appliances," Cullens continued. "We believe that our TriLink(TM), UltraLine(TM) and Westell MediaStations(TM) product families have positioned us to help enable the service providers to take advantage of these new markets in an effective and timely manner. A substantial additional investment will be required for Westell to fully capitalize on the many opportunities we have before us. Development of the advanced broadband market is taking longer then expected, but it is coming," Cullens said.
Westell provided guidance for the first fiscal quarter ending June 30, 2006. The Company expects revenue to be in a range of $64 to $67 million. Westell expects EPS to be in a range of $0.02 to $0.03 per diluted share (including a provision for income tax expense in the range of $1.4 million to $2.2 million). The Company's effective tax rate for fiscal 2007 approximates 39%. Westell does not expect to incur any significant cash tax payments for the foreseeable future as a result of the anticipated utilization of net operating loss carryforwards to reduce its cash tax liabilities. The revenue guidance reflects the expected mix of customer promotional activities and the historical seasonality in the June quarter. EPS guidance reflects substantially increasing R&D, marketing and sales expenses, to support expected market growth that is likely to continue into the foreseeable future.
Conference Call Information
Conference Plus, Inc. (ConferencePlus), a Westell subsidiary, will manage Westell's fourth quarter fiscal 2006 earnings conference call on Friday, May 12, at 9:30 AM ET using its new EventManager(TM) Service.
Westell will release its March 2006 fourth quarter results post market close on Thursday, May 11 and host its earnings call on Friday, May 12, at 9:30 AM ET for analysts, shareholders, investors and the public. Participants can register for the Westell conference by going to the URL:
http://www.conferenceplus.com/westell
With EventManager, participants can quickly register online in advance of the conference through a customizable web page that can be used to gather multiple pieces of information from each participant, as specified by the event arranger. After registering, participants receive dial-in numbers, a passcode, and a personal identification number (PIN) that is used to uniquely identify their presence and automatically join them into the audio conference. A URL is also provided to join the web presentation portion of the conference. If a participant experiences any technical difficulties after joining the conference on May 12, simply press star 0 for support.
If you do not wish to register, you can participate only in the audio portion of the call on May 12 by dialing ConferencePlus at 1-877-875-0056 no later than 9:15 AM, Eastern Time and using confirmation number 14609622. International participants may dial 1-847-585-4340.
The Company's earnings press release and any related earnings information to be discussed on the earnings conference will be posted on the Investor Relations section of the Company's website at http://www.westell.com. An archive of the entire conference will be available on Westell's website or via Digital Audio Replay one hour following the conclusion of the conference. The audio-only portion of the conference can be accessed by dialing 1-888-843-8996 or 1-630-652-3044 and entering 8274324#.
About Westell
Westell Technologies, Inc., headquartered in Aurora, Illinois, is a holding company for Westell, Inc. and ConferencePlus, Inc. Westell, Inc. manufactures broadband telecommunications access products. ConferencePlus, Inc. is a collaborative Application Service Provider that manages and hosts voice, video, IP applications and back-office services. Additional information can be obtained by visiting Westell's Web site at www.westell.com.
About ConferencePlus
ConferencePlus, a Westell Technologies, Inc. (WSTL, Trade) subsidiary, is a leading global provider of audio, web, video and IP conferencing services. ConferencePlus is dedicated to providing high quality, innovative conferencing solutions to its domestic and international clients and telecommunications resellers. ConferencePlus is recognized for outstanding customer service and support to help clients meet their business objectives. The company is headquartered in Schaumburg, Illinois with an international headquarters in Dublin, Ireland. Additional information can be obtained by visiting the ConferencePlus web site at www.conferenceplus.com.
"Safe Harbor" statement under the Private Securities Litigation Reform Act 1995:
Certain statements contained herein including, without limitation, statements containing the words "believe," "on track, " "anticipate," "focus," "should," "committed" "expect," "estimate", "await," "continue," "intend," "may," "will," "should," and similar expressions are forward looking statements that involve risks and uncertainties. These risks include, but are not limited to, product demand and market acceptance risks, need for financing, the economic downturn in the U.S. economy and telecom market, the impact of competitive products or technologies, competitive pricing pressures, product development, excess and obsolete inventory due to new product development, commercialization and technological delays or difficulties (including delays or difficulties in developing, producing, testing and selling new products and technologies), the effect of Westell's accounting policies, the need for additional capital, the effect of economic conditions and trade, legal social and economic risks (such as import, licensing and trade restrictions) and other risks more fully described in Westell's Annual Report on Form 10-K for the fiscal year ended March 31, 2005 under the section "Risk Factors". Westell undertakes no obligation to release publicly the result of any revisions to these forward looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Financial Tables to Follow:
Westell Technologies, Inc.
Financial Results
(Dollars in thousands except per share amounts)
Three Months ended Twelve Months
March 31, % ended March 31, %
2006 2005 Change 2006 2005 Change
-------- -------- ------ -------- -------- ------
Revenues
NSA $12,422 $8,997 38% $43,319 $42,481 (1) 2%
CNE 49,100 57,792 -15% 194,782 183,384 6%
Services 11,543 11,452 1% 45,070 44,398 2%
-------- -------- -------- --------
Total revenues 73,065 78,241 -7% 283,171 270,263 5%
-------- -------- -------- --------
Gross profit
Equipment 15,837 16,553 63,306 58,543 (1)
Services 5,945 6,264 22,493 22,657
-------- -------- -------- --------
Total gross
profit 21,782 22,817 -5% 85,799 81,200 6%
-------- -------- -------- --------
Gross margin
Equipment 25.7% 24.8% 26.6% 25.9%(1)
Services 51.5% 54.7% 49.9% 51.0%
-------- -------- -------- --------
Total gross
margin 29.8% 29.2% 30.3% 30.0%
-------- -------- -------- --------
Operating expenses
Sales &
marketing 6,513 5,590 17% 24,852 22,211 12%
Expense to
revenue 8.9% 7.1% 8.8% 8.2%
General &
administrative 4,199 4,146 1% 16,543 17,368 -5%
Expense to
revenue 5.7% 5.3% 5.8% 6.4%
Research &
development 5,414 4,756 14% 20,274 15,911 27%
Expense to
revenue 7.4% 6.1% 7.2% 5.9%
Restructuring - (341) 443 (793)
Expense to
revenue 0.0% -0.4% 0.2% -0.3%
Intangibles
amortization 414 324 1,386 1,335
Expense to
revenue 0.6% 0.4% 0.5% 0.5%
-------- -------- -------- --------
Total operating
expenses 16,540 14,475 14% 63,498 56,032 13%
-------- -------- -------- --------
Expense to
revenue 22.6% 18.5% 22.4% 20.7%
Gain on sale
of assets - - - 1,453 (2)
Operating income 5,242 8,342 -37% 22,301 26,621 -16%
Other income 575 109 974 896
Interest expense (1) (3) -67% (12) (60) -80%
-------- -------- -------- --------
Income before
minority
interest and
taxes 5,816 8,448 -31% 23,263 27,457 -15%
-------- -------- -------- --------
Income taxes 3,202 (4)(20,122)(3) 10,112 (12,757)(3)
Minority
interest 104 196 304 520
Net income $2,510 $28,374 $12,847 $39,694
======== ======== ======== ========
Income per
common share:
Basic 0.04 0.41 0.18 0.58
-------- -------- -------- --------
Diluted 0.04 0.40 0.18 0.56
-------- -------- -------- --------
Average number
of common shares
outstanding:
Basic 70,307 68,801 69,938 68,473
Diluted 71,712 71,593 71,622 71,042
Footnotes:
(1) The Company earned $883,000 in the three months ended June 30,
2004 for a contractual settlement.
(2) Includes a $1.5 million gain from the sale of NSA assets.
(3) The Company recorded a tax benefit from the release of valuation
allowances against net operating loss carryforwards.
(4) The Company recorded $ 785,000 of additional valuation allowance
resulting primarily from state net operating loss carryforwards
that the Company no longer believes will be utilized.
Westell Technologies, Inc.
Financial Results (continued)
(Dollars in thousands)
March 31, March 31,
2006 2005
---------- ----------
Cash and Short term Investments 42,215 26,960
Receivables 30,121 30,167
Inventory 23,918 26,419
Total current assets 107,401 90,332
Goodwill and intangibles 18,479 13,883
Total assets 191,813 180,090
Total current liabilities 30,859 35,812
Total liabilities and minority interest 34,536 40,432
Shareholders' Equity 157,276 139,658
Days Sales Outstanding 37 35
SOURCE: Westell Technologies, Inc.
Westell Technologies Inc.
Nicholas C. Hindman, Sr., 630-375-4136
nhind@westell.com
or
KGT Communications Group
Trade/Business Press:
Ken Trantowski, 630-469-8765
kennethg_trantowski@msn.com
ZIXI news --- Zix Corporation Announces Technology Alliance Agreement with EpicTide Email Encryption Services to Enhance EpicTide`s Healthcare and Financial Applications
May 11, 2006 15:00:02 (ET)
DALLAS, May 11, 2006 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)), (ZIXI, Trade), the leader in hosted services for email encryption and e-prescribing, today announced a technology alliance with EpicTide, a leading provider of security information management solutions. EpicTide will seamlessly augment and integrate its healthcare and financial service offerings with ZixCorp's email encryption gateway service, ZixVPM(R) (Virtual Private Messenger).
EpicTide provides solutions that centralize organizations' audit logs and address compliance and information security vulnerabilities. Its flagship product, EpicTide FairWarning, will have the ability to read the audit logs of ZixVPM and combine them with a whole view of the audit logs across an enterprise. This capability enables security officers to audit user behavior across their entire suite of applications.
"The combined solution of EpicTide's FairWarning and ZixVPM will be the first to provide affordable monitoring, security, and auditing for applications and messaging," said Kurt Long, chief executive officer for EpicTide. "We're delighted to include ZixCorp's services in our lineup. ZixCorp's significant market presence in healthcare and financial services made our support a no-brainer."
ZixVPM is an on-site service that provides company-wide, content filtering and policy-based encryption of outgoing email. It is standards based and can deliver encrypted email to anyone. It uses S/MIME, PGP, and TLS protocols to deliver to gateways and encrypted email users. In addition, ZixVPM can deliver encrypted email using zero footprint solutions.
"EpicTide's focus on healthcare and financial markets complements ZixCorp's strengths," said Rick Spurr, chief executive officer for ZixCorp. "We're committed to partnering with high-quality companies that can take advantage of our interoperability, fast deployment, and usability to offer their customers the comprehensive security services on the market."
About EpicTide
EpicTide is a leader in solutions that help organizations increase their security responsiveness, automate compliance and reduce associated costs. The company is privately held and is located in St. Petersburg, Fla. To learn more about EpicTide, Inc., visit the company Web site at www.epictide.com or call the company at 1-866-602-8433 (U.S. toll free) or +1 727 576 6700 (international).
About Zix Corporation
Zix Corporation (ZixCorp(R)) provides easy-to-use-and-deploy email encryption and e-prescribing services that protect, manage, and deliver sensitive information to the healthcare, finance, insurance, and government industries. ZixCorp's email encryption services enable policy-driven email security, content filtering, and send-to-anyone capability. Its e-prescribing service provides point-of-care access and transmission of patient and payor data that improves patient care, reduces costs, and improves efficiency. For more information, visit www.zixcorp.com.
SOURCE: Zix Corporation
Zix Corporation, Dallas
Public Relations:
Farrah Corley, 214-370-2175
publicrelations@zixcorp.com
or
Investor Relations:
Peter Wilensky, 214-515-7357
invest@zixcorp.com
All right all you puffers...sign up and quit smoking. And support one of by favorite stocks. LOL!
FDA approves Pfizer`s smoking-cessation drug
May 11, 2006 12:23:00 (ET)
BOSTON (MarketWatch) -- The Food and Drug Administration announced Thursday that it has approved Pfizer's smoking-cessation pill Chantix, making it the first new product to be approved for such use in almost a decade.
Differing from most other leading anti-smoking products, Chantix does not contain nicotine. It works by mimicking some of nicotine's effects in the brain in order to reduce the symptoms of nicotine withdrawal. If the smoker relapses and lights up, the product can also help block the pleasurable sensations associated with nicotine.
Until now, smokers seeking to quit have had to generally rely on nicotine-based products, such as gums and patches, or the anti-depressant Wellbutrin, also marketed under the brand-name Zyban. Like Zyban, Chantix will only be available by prescription.
The FDA said that Chantix is approved to be taken for 12 successive weeks, and can be re-prescribed for an additional 12 weeks if needed. The agency's approval of the drug had been generally expected.
While studies show the Chantix can be more effective than Zyban, only 20% of Chantix users remained smoke-free after one year. However, Pfizer (PFE, Trade) also noted that the long-term success rate among smokers who quit without assistance is less than 7%.
Some analysts Thursday also questioned how well the prescription drug will fare in a market dominated by more readily-accessible, over-the-counter products.
"It's about 50 to 100 times better than Zyban, but the question is, 'Is that still enough?'" said Natexis Bleichroeder analyst John LeCroy, who estimates Chantix's peak annual sales should reach $500 million. "We just haven't seen a major blockbuster in this market yet."
SCLD - news... SteelCloud Receives Multi-Year $3.4M Contract Award
May 11, 2006 11:10:42 (ET)
DULLES, Va., May 11, 2006 /PRNewswire-FirstCall via COMTEX/ -- SteelCloud Inc. (SCLD, Trade), a leading Supplier of turnkey appliance servers, network security infrastructure solutions, and professional services today announced it has received a $3.4M, three-year contract for software which will be used within an agency under the auspices of the Department of Homeland Security. SteelCloud will deliver network security and management software, from one of the Company's channel partners, to a prime contractor who is responsible for the overall technology refreshment of the agency's IT infrastructure. The contract also provides the Company with an opportunity to market additional products and services into the Department of Homeland Security.
"This is the second multi-million dollar, multi-year technology refresh agreement we've closed in fiscal 2006," said Brian H. Hajost, SteelCloud President. "Our federal government market experience provides us with the insight to help these organizations continue to deploy the most effective IT solutions. This multi-year contract provides the customer with a continual flow of new, state-of-the art technology. Multi-year contracts also benefit SteelCloud as they foster customer satisfaction, build back log, and promote repeat business."
Initial deliveries for the first year of this 3-year contract began in the Company's fiscal second quarter, which ended April 30, 2006.
Tech - you might not want to....news>>PainCare Holdings Clarifies Relationship With Solstice Neurosciences, Inc.
PR Newswire - May 11, 2006 11:49 AM (EDT)
Jump to first matched term
Orlando, Fla., May 11, 2006 /PRNewswire-FirstCall via COMTEX/ -- PainCare Holdings, Inc. (Amex: PRZ), one of the nation's leading providers of pain-focused medical and surgical solutions and services, today issued a clarification on a news announcement released yesterday afternoon by Solstice Neurosciences, Inc. that was not pre-approved, nor authorized for release, by PainCare officials. Although the Company has held preliminary discussions with Solstice regarding instituting a proposed screening program at one or more of its practices, no formal understanding or contractual agreement between the companies exists at this time.
About PainCare Holdings, Inc.
Headquartered in Orlando, Florida, PainCare Holdings, Inc. is one of the nation's leading providers of pain-focused medical and surgical solutions and services. Through its proprietary network of acquired or managed physician practices and ambulatory surgery centers, and in partnership with independent physician practices and medical institutions throughout the United States and Canada, PainCare is committed to utilizing the most advanced science and technologies to diagnose and treat pain stemming from neurological and musculoskeletal conditions and disorders.
Through its majority-owned subsidiary, Amphora, the Company is also engaged in providing advanced Intraoperative Monitoring (IOM) and interpretation services to hospitals and surgeons; and through its wholly- owned subsidiary, Caperian, Inc., PainCare offers medical real estate and development services.
For more information on PainCare Holdings, please visit http://www.paincareholdings.com .
CPNLQ - moving up strongly today...
IRIS - bounce continues
(bôr, br)
tr.v. bored, bor·ing, bores
To make weary by being dull, repetitive, or tedious: The movie bored us.
n.
One that is wearingly dull, repetitive, or tedious.
One note...that addiction for fast cars is true. LOL!
23 14 in 1's eom
VSR news after the bell.... VERSAR, Inc. Awarded Design Portion Of $8.1 Million Municipal Design Build Contract
May 10, 2006 16:05:32 (ET)
SPRINGFIELD, Va., May 10, 2006 /PRNewswire-FirstCall via COMTEX/ -- VERSAR, Inc. (VSR, Trade) announced today it was competitively selected and awarded $625,000 representing the design portion of a not to exceed $8.1M design-build contract for the design and construction of two new municipal aquatic centers for the Town of Gilbert, Arizona. In the last two decades, Gilbert has grown at a pace unparalleled by most communities in the United States (12% annually) and continues to make significant investments in municipal infrastructure to support this growth. The Town has partnered with the Chandler, AZ Unified School District and the Higley, AZ Unified School District to build two new competitive aquatic facilities adjacent to new high schools currently under contract for construction.
VERSAR's Tempe, Arizona office has been providing Architecture, Engineering, and construction management services to its municipal clients in the southwestern U.S. and the metropolitan Phoenix area since 1986. The Town of Gilbert is a longstanding customer. The design portion, funded at $625,000, will begin immediately. Upon negotiation of the final construction price construction, VERSAR is anticipated to begin construction by October 2006 with completion scheduled in August 2007. The new facilities will be opened at the start of the 2007-2008 school year. The final construction price is subject to negotiation and approval by the town.
Dr. Ted Prociv, President and CEO said, "I am excited to see the continued growth and success of our Western regional offices. Furthermore, I am delighted that the engineering and construction services VERSAR provides will be used to enhance the quality of life for the residents of the communities where we live and work. The selection of VERSAR by the Town of Gilbert solidifies our commitment to provide Infrastructure and Management Services to our customers and demonstrates the broad services we offer in architecture, engineering, and construction."
VERSAR, INC., headquartered in Springfield, VA, is a publicly held infrastructure program management company for the Federal Government and the commercial market specializing in homeland defense, engineering and construction management, environmental health and safety and the management of toxic and hazardous materials. VERSAR operates a number of web sites, including the corporate Web sites, http://www.versar.com, http://www.homelanddefense.com, and http://www.geomet.com; and a B2B portal for homeland defense products and services, http://www.nbcprotect.com and http://www.dtaps.com.
This press release contains forward-looking information. The forward- looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar's Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended July 1, 2005. The forward-looking statements are made as of the date hereof and Versar does not undertake to update its forward-looking statements.
Contact: James Dobbs (703) 642-6712
Senior Vice President
Email: jdobbs@versar.com
Investor Relations Contact: Andrew J. Kaplan (732) 747-0702
Barry Kaplan Associates
623 River Road
Fair Haven, NJ 07704
Email: smallkap@aol.com
lMAO! Right on! eom
you think that's a bottom???? I'm not so sure... eom
IPIX - earnings out...in at 1.48..
IPIX Reports Results for First Quarter 2006
Business Wire - May 10, 2006 12:58 PM (EDT)
Jump to first matched term
RESTON, Va., May 10, 2006 (BUSINESS WIRE) -- IPIX Corporation (NASDAQ:IPIX), a premier supplier of 360-degree, immersive imaging technologies for visual intelligence applications, announced results for its first quarter ended March 31, 2006.
Revenue for the quarter was $1.91 million, a 186% increase from the same period in the previous year. Net loss to common shareholders for the first quarter was ($3.86) million or ($0.14) per share compared to ($6.00) million or ($0.27) per share in the comparable period a year ago. In the year ago quarter, net loss to common shareholders included loss from discontinued operations of ($1.36) million or ($0.06) a share. There was no loss from discontinued operations in the first quarter of 2006.
In the first quarter, hardware revenue increased 93% as our video products achieved increased traction in the market. Professional service revenue was a material revenue source in the quarter under IPIX's $2.4 million research contract with the Department of Defense Advanced Research Projects Agency (DARPA) to research and build the world's highest resolution video camera. There was no services revenue in the same period in 2005.
Operating expenses declined approximately 18% in the quarter versus the same period last year as IPIX experienced savings from its prior years' restructuring activities as well as reductions in legal and Sarbanes Oxley compliance expenses. R&D expenses decreased as some of these costs were allocated to cost of goods sold for work done under contract to DARPA.
"I am very pleased with the progress we have made in the first quarter," said IPIX President and CEO Clara Conti. "IPIX continues to gain traction in its vertical markets and streamline its operations for greater efficiency."
IRIS - ))))))))) eom
IRIS bounce started.....
IRIS bounce started.....
MWC - lol maybe...watching & waiting. eom
Rick Dees
http://www.foxy-productions.com/DiscoDuck.html
Went to a party the other night...
All the ladies were treating me right...
Moving my feet to the disco beat...
How in the world could I keep my seat!!!
All of a sudden I began to change...
I was on the dance floor acting strange...
Flapping my arms I began to cluck...
Look at me...
I'm the disco duck!!!
Ah...get down mama
I've got to have me a woman!!!
Ha Ha Ha Ha Ha
Disco...Disco Duck
Got to have me a woman...
Disco...Disco Duck
Oh...get down mama
Try your luck...
Don't be a cluck...Disco
Disco
Disco
Disco
Disco
Disco
Disco...Disco Duck
All right...
Disco...Disco Duck
Ah...get down mama...
Oh mama...
Shake your tail feather...
Ha Ha Ha Ha Ha
When the music stopped...
I returned to my seat.
But there's no stoppin' a duck...
and his beat!!!
So I got back up to try my luck...
Why look...
Everybody's doin' the
Disco...Disco Duck...
Disco...Disco Duck...
Try your luck...
Wave to me!!!
Don't be a cluck!
I'm so happy to be here...
Disco...
Thank you duck!!!
Disco...
For gettin' down
Disco...Disco...Disco
Thank you so very much!!!
Disco Duck
You're welcome!!!
Disco...Disco Duck
Try your luck...
Don't be a cluck...
Disco...Disco...Disco...
*1* DISCO DUCK- Rick Dees- Autentic Trash disco. A perfect excuse for the people who didn't like disco make fun at the style.
*2* DIS-GORILLA- Rick Dees- Before vanishing, Rick Dees gave us this "pearl".
*3* D' YA THINK I'M SEXY- Rod Stewart- Terrible Disco experience Rod Stewart made, and the worst of all: It's his biggest hit...
*4* DISCO DOG- Birmighan & Eggs- As you can see, disco and animals has never been a great mixture...
*5* TERROR ON THE DANCE FLOOR- Dracula & Co- It was reaaly terror. People used to get so frightened, that the dance floor used to become empty in seconds.
*6* BLACK CAT- Rafaella Carra- Rafaella is a terrible italian singer far from being a disco diva
*7* BODY STRONG- Sylvester- You make my body strong, and so now what?
*8* TROUBLE MAKER- Roberta Kelly- Thank God, Zodiacs came up quickly.
*9* GET DANCIN'- Disco Tex & The Sex O-lettes- Trash disco and a bad live record!
*10* CALENDAR SONG- Boney M.- What could I say about a song that the lyrics are simply the months of the year?
*11* DOUBLE DUTCH BUS- Frankie Smith- Frankie's voice is really annoying. It seems he's throwing up!
*12* BEATLES MEDLEY- Cafe Creme- Beatles Disco Megamix- the results couldn't be worse...
*13* UPTOWN FESTIVAL- Shalamar- Another megamix of the 60's songs. But I forgive Shalamar. They found their way.
*14* SUNSET PEOPLE- Donna Summer- I always skip this song in the "Greatest hits"cd...
*15* D.I.S.C.O.- Ottawan- Totally S.I.L.L.Y.!
*16* CALL ME- Andrea True Connection- Not bad at all, but impossible to compare it to "More More More"
*17* MY HEART'S BEATING WILD (TIC TAC)- Gibson Brothers- impossible to listen to this song seriously.
*18* THINK IT OVER- Cheryl Ladd- She's much better as Kris in Charlie's Angels. Really.
*19* MORE THAN A WOMAN- Bee Gees- Tavares version is much better.
*20* DISCO MANIA- Lovers- Scary disco medley! Worse than this one, just the Village People Kids!
now that you have...aren't you ashamed?
LOL!
JK!!!!!!!!
Z
ZIXI - Q1 results >>> Zix Corporation Announces First Quarter 2006 Financial Results
May 09, 2006 16:10:01 (ET)
DALLAS, May 09, 2006 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)), (ZIXI, Trade), the leader in hosted services for email encryption and e-prescribing, today announced financial results for the first quarter ended March 31, 2006. ZixCorp recorded first quarter revenues of $3.9 million and recorded a first quarter 2006 net loss of $6.9 million, or 14 cents loss per share, compared with revenue of $3.6 million and a net loss of $9.6 million, or 30 cents loss per share, in the corresponding 2005 quarter.
"Our focus on two service offerings, hosted email encryption and e-prescribing, has helped propel ZixCorp's expansion success," said Rick Spurr, chairman and chief executive officer for ZixCorp. "In our email encryption business, we continue to see the customer base grow and the renewal rate remains at or above 95 percent. To effect even greater growth, we have been investing in new alliances and channels of distribution through partnerships. Adding to two significant partnerships announced in 2005, we announced agreements with SafeBoot and Panda in this quarter. Some of these new partnerships have expanded our reach beyond the United States, into Europe and Asia.
"In e-prescribing, our recent announcements of payor sponsorships with Blue Cross and Blue Shield of Louisiana and a payor in the Southeast add to our active, successful programs in Massachusetts, New Jersey, and Pennsylvania. These wins demonstrate our expanding leadership role in this exciting, emerging new market."
Q1 Business Highlights
e-Prescribing
Processed 1.2 million electronic prescriptions in Q1 2006, which is more than 100,000 prescriptions per week, up from 80,000 per week in December 2005.
-- Achieved 885 new e-prescriber deployments in the quarter.
-- eRx Collaborative sponsored 500 additional prescribers and
published statistics from the most active e-prescribing
program in the United States, including:
-- 1.5 percent drug cost savings
-- 5,500 changed prescriptions per month due to real-time
alerts
-- Average savings to patient of $20-$25 for each changed
prescription
-- Other payor pilot programs are producing similar or stronger
measurable changes in prescribing behavior through increases
in generic substitution and in formulary compliance.
Email Encryption:
-- Email encryption revenue for Q1 2006 increased 63 percent when compared with Q1 2005 and 17 percent when compared with Q4 2005.
-- Total email encryption orders were $4.1 million, which was the highest level since Q2 2005.
-- Email encryption's new first-year orders were $1 million.
-- Announced an OEM distribution agreement with SafeBoot, a worldwide desktop encryption provider, which expands ZixCorp distribution into Europe and Asia.
-- Postini launched and announced a ZixCorp reseller relationship.
ZixData Center(TM)
-- Transaction throughput consisting of both email messages and electronic prescriptions more than doubled from a year ago, with 533 million transactions in Q1 2006.
Financial Highlights for the Quarter
Revenues: Revenues were $3.9 million in the first quarter 2006, which was a 9 percent increase over the first quarter 2005. The increase was negatively impacted by products the company divested in 2005. When the revenues for divested products are removed and only the company's current products remain, the total revenues increased by 35 percent in the first quarter 2006 compared with the first quarter 2005. The company's email encryption services increased revenue year-over-year by 63 percent, while e-prescribing declined by 32 percent. Email encryption's rise was due to the record orders the company experienced in first and second quarters of 2005, which are now fully in service and being recognized into revenue. e-Prescribing revenues declined due to several factors, including the impact of changes in the recent contract terms leading to all revenue on new arrangements being recognized ratably over the contract term, the inclusion of more performance-based contract requirements, and the drop off of revenues from the Wellpoint initiative. The company's order backlog (contractually bound service contracts that represent future revenue to be recognized as the services are provided) was $22.5 million on March 31, 2006.
Revenues by Product First Quarter 2005 - 2006
Three months ended, Variance
Mar 31, 2006 vs. 2005
----------------------- ------------------
2006 2005 $ %
----------- ----------- ----------- ------
Email encryption $3,333,000 $2,044,000 $1,289,000 63%
e-Prescribing 562,000 832,000 (270,000) (32%)
----------- ----------- -----------
Subtotal for core products 3,895,000 2,876,000 1,019,000 35%
Inspector products (sold
March 2005) -- 637,000 (637,000) (100%)
Dr. Chart (sold September
2005) -- 70,000 (70,000) (100%)
----------- ----------- -----------
Subtotal divested products -- 707,000 (707,000) (100%)
----------- ----------- -----------
Total revenues $3,895,000 $3,583,000 $312,000 9%
=========== =========== ===========
Gross Margin: Company-wide gross margin grew by $0.8 million, compared with the first quarter 2005, to reach $0.5 million for the first quarter 2006, or 13 percent of revenue. The gross margin contribution from email encryption services was over $1.9 million (56 percent), while gross margin for e-prescribing services remained negative, at an estimated $1.4 million for the first quarter 2006. The company-wide gross margin for the same period in 2005 was negative $0.3 million or negative 9 percent, with gross margin for email encryption estimated to be positive $ 0.7 (36 percent) and for e-prescribing at negative $1 million. The year-on-year improvement in email encryption services gross margin was caused by continued revenue growth on a largely fixed cost base for providing the incremental services. The gross margin in e-prescribing declined year-over-year, primarily due to the decline in revenue.
R&D and SG&A Expenditures: In the first quarter 2006, the combination of the company's research and development (R&D) expenditures and its sales, general, and administrative (SG&A) expenditures decreased by $1.3 million when compared with the same period in 2005, representing a decline of 14 percent. The spending declined as a result of divested products and general cost-cutting, with a partially offsetting increase of $0.7 million from the implementation of FAS 123R (expensing of stock options).
Net Loss: ZixCorp recorded a net loss of $6.9 million for the first quarter 2006 versus a net loss of $9.6 million in first quarter 2005. The $2.7 million decline in the net loss is from the improved gross margin, declines in SG&A and R&D spending as mentioned above, and a reduction of net interest expense of $0.5 million. Two one-time gains in each quarter of $1.0 million offset each other on a comparative basis.
Cash Utilization: Unrestricted cash and cash equivalents as of March 31, 2006, was $14.2 million, a $6 million decrease from Dec. 31, 2005. Net cash used by operating activities in the first quarter 2006 was $5.5 million, which was a decline of $1.8 million over the same period in 2005. The company also has a restricted cash balance on hand of $5.1 million that is primarily held in escrow for $5 million of outstanding convertible debt.
Subsequent Events: On April 5, 2006, ZixCorp completed a private placement of the company's common stock. Total proceeds from the transaction were approximately $11.8 million (net proceeds to the company were approximately $10.9 million after estimated transaction costs). The transaction resulted in the company issuing 9,930,000 shares of its common stock and 5,958,000 warrants to purchase the company's common stock. Details of this transaction can be found in the company's recently filed 8-K, filed April 5, 2006.
Annual Meeting of Stockholders: ZixCorp's Annual Meeting of Stockholders and Webcast has been rescheduled for June 13, 2006. The meeting will begin at 10:00 a.m. CDT (11:00 a.m. EDT). Registration begins at 9:30 a.m. CDT. The meeting will be held at the Cityplace Conference Center, Turtle Creek Room I, Ground Floor, 2711 North Haskell Avenue, Dallas, Texas 75204. For a live Webcast of the Annual Meeting of Stockholders, go to http://investor.zixcorp.com/, then click the Live Webcast icon. A replay will be available at the Web site.
About Zix Corporation
Zix Corporation (ZixCorp(R)) is the leading provider of hosted email encryption and e-prescribing services. ZixCorp's email encryption services provide an easy and cost-effective way to ensure customer privacy and regulatory compliance for corporate email. Its PocketScript(R) e-prescribing service reduces costs and improves patient care by automating the prescription process between payers, doctors, and pharmacies. For more information, visit www.zixcorp.com.
Safe Harbor Statement for ZixCorp
The following is a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained in this release are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to, the following: the company's continued operating losses and substantial utilization of cash resources; the company's ability to achieve broad market acceptance for the company's products and services, including the company's ability to enter into new sponsorship agreements for the electronic prescribing services offered by its PocketScript, Inc. subsidiary; the company's ability to maintain existing and generate other revenue opportunities, including fees for scripts written, from its PocketScript e-prescription business; reliance on establishing and maintaining strategic relationships to gain customers and grow revenues; the expected increase in competition in the company's e-messaging and e-prescription businesses; and the company's ability to successfully and timely introduce new e-messaging and electronic prescription products and services or related products and services and implement technological changes. Further details on such risks and uncertainties may be found in the company's public filings with the SEC.
ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended March 31,
2006 2005
-------------- --------------
Revenues $3,895,000 $3,583,000
Cost of revenues 3,375,000 3,891,000
-------------- --------------
Gross margin (loss) 520,000 (308,000)
Operating expenses:
Research and development expenses 1,595,000 1,975,000
Selling, general and administrative
expenses 6,592,000 7,502,000
Customer deposit forfeiture (1,000,000) --
Gain of sale of product lines -- (950,000)
-------------- --------------
Total operating expenses 7,187,000 8,527,000
-------------- --------------
Operating loss (6,667,000) (8,835,000)
Other (expense) income:
Investment and other income 217,000 143,000
Interest expense (418,000) (830,000)
-------------- --------------
Total other (expense) income (201,000) (687,000)
-------------- --------------
Loss before income taxes (6,868,000) (9,522,000)
Income taxes (6,000) (50,000)
-------------- --------------
Net loss $(6,874,000) $(9,572,000)
============== ==============
Basic and diluted loss per common share $(0.14) $(0.30)
============== ==============
Basic and diluted weighted average common
shares outstanding 49,654,338 32,295,162
============== ==============
ZIX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
March 31, December 31,
2006 2005
------------ ------------
ASSETS
Current assets:
Cash and cash equivalents $14,158,000 $20,240,000
Restricted cash 5,102,000 5,100,000
Receivables, net 413,000 149,000
Prepaid and other current assets 1,654,000 1,845,000
------------ ------------
Total current assets 21,327,000 27,334,000
Restricted cash 35,000 35,000
Property and equipment, net 3,377,000 3,652,000
Goodwill, intangible assets and other assets 2,865,000 3,094,000
------------ ------------
Total assets $27,604,000 $34,115,000
============ ============
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $4,547,000 $5,062,000
Deferred revenue 7,824,000 7,087,000
Customer deposit 2,020,000 1,000,000
Capital lease obligations 103,000 165,000
Promissory note payable 2,330,000 --
Short-term note payable 192,000 268,000
Convertible promissory notes payable 4,504,000 4,404,000
------------ ------------
Total current liabilities 21,520,000 17,986,000
Long-term liabilities:
Deferred revenue 1,325,000 1,261,000
Customer deposit -- 2,000,000
Promissory note payable -- 2,226,000
Deferred rent 239,000 245,000
------------ ------------
Total long-term liabilities 1,564,000 5,732,000
------------ ------------
Total liabilities 23,084,000 23,718,000
Total stockholders' equity 4,520,000 10,397,000
------------ ------------
Total liabilities and stockholders'
equity $27,604,000 $34,115,000
============ ============
ZIX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended March 31,
2006 2005
--------------- -------------
Operating activities:
Net loss $(6,874,000) $(9,572,000)
Non-cash items in net loss 1,043,000 1,031,000
Changes in operating assets and
liabilities, excluding effects of
acquisitions: 285,000 1,155,000
--------------- -------------
Net cash used by operating activities (5,546,000) (7,386,000)
Investing activities:
Purchases of property and equipment (398,000) (685,000)
Sales and maturities of marketable
securities -- 12,997,000
Purchase of restricted cash investment -- (36,000)
Proceeds from sale of product line -- 1,840,000
--------------- -------------
Net cash (used) provided by investing
activities (398,000) 14,116,000
Financing activities:
Proceeds from exercise of stock options -- 3,000
Payment of short-term notes payable,
capital leases and other (138,000) (109,000)
--------------- -------------
Net cash used by financing activities (138,000) (106,000)
--------------- -------------
(Decrease) increase in cash and cash
equivalents (6,082,000) 6,624,000
Cash and cash equivalents, beginning of
period 20,240,000 3,856,000
--------------- -------------
Cash and cash equivalents, end of period $14,158,000 $10,480,000
=============== =============
SOURCE: Zix Corporation
Zix Corporation, Dallas
Public Relations:
Farrah Corley, 214-370-2175
publicrelations@zixcorp.com
or
Investor Relations:
Peter Wilensky, 214-515-7357
ZIXI news -- Zix Corporation and ScriptSave to Provide Uninsured Patients Drug Discount via PocketScript(R); PocketScript Can Introduce New Services in Real Time at the Point of Care
Business Wire - May 9, 2006 3:36 PM (EDT)
Jump to first matched term
DALLAS, May 09, 2006 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)), (Nasdaq:ZIXI), the leader in hosted services for email encryption and e-prescribing, today announced it has entered into an agreement with Medical Security Card Company to offer its ScriptSave(SM) program, America's premier prescription savings program, to uninsured patients. ScriptSave will provide patients with an average savings of 21 percent on their prescriptions at over 52,000 pharmacies nationwide.
According to the 2004 U.S. Census nearly 16 percent of the non-Medicare eligible population, over 45 million people, are without health insurance.
With this new service, physicians who have opted into the program will be notified at the point of care when a patient does not have a drug benefit. The system will prompt the physician to ask the patient if he/she is interested in signing up for ScriptSave at no charge. The discount will be extended to the entire family. In addition, the program may also be available to insured patients if the prescribed drug is not covered by their health plans. ScriptSave is an independent drug discount program.
"ZixCorp is constantly evaluating how its e-prescribing service can be expanded to further increase adherence and patient safety. Together with the industry leading ScriptSave, we can reach a broader base of uninsured patients and offer a quick and easy solution for the high cost of prescription drugs," said Rick Spurr, chief executive officer for ZixCorp. "Both physicians and health plans around the country see the tremendous value that the drug discount opportunity brings to local communities by reducing out of pocket expenses for those who don't have insurance and increasing adherence to filling those prescriptions, leading to improved healthcare."
PocketScript enables physicians, through a handheld PDA, to write prescriptions and then send them immediately to pharmacies electronically, improving patient convenience. Prescriptions can also be written and managed through a ZixCorp secure Web site using a common browser. During the prescribing process, the application provides real-time formulary information, a drug reference guide, drug-to-drug and drug-to-allergy checking, and patient-specific drug-dispensed lists.
"Our partnership with ZixCorp provides an opportunity for ScriptSave to reach the most vulnerable population, America's uninsured, when they can benefit the most. Coupling the technology of both ZixCorp and ScriptSave allows doctors' to provide assistance to their patients and help ensure compliance and better health outcomes," said Lori Bryant, President and CEO of Tucson, Arizona based Medical Security Card Company. "We see the partnership between ZixCorp and our ScriptSave product as being a win for everyone involved in the healthcare chain - and most especially patients who need affordable prescription drugs."
About ScriptSave
Tucson, Arizona based Medical Security Card Company (MSC) began operations in 1994. Its primary program is ScriptSave(SM), America's Premier Prescription Savings Program. ScriptSave has saved cardholders more than $1 billion on their prescription drugs. These valuable savings are why millions of Americans rely on ScriptSave to provide them with the most value for every pharmacy dollar. MSC has been widely recognized for its work environment and employee empowerment programs as well as its award-winning customer service. For more information about MSC/ScriptSave please call 1-800-347-5985.
About Zix Corporation
Zix Corporation (ZixCorp(R)) is the leading provider of hosted email encryption and e-prescribing services. ZixCorp's email encryption services provide an easy and cost-effective way to ensure customer privacy and regulatory compliance for corporate email. Its PocketScript(R) e-prescribing service reduces costs and improves patient care by automating the prescription process between payers, doctors, and pharmacies. For more information, visit www.zixcorp.com.
SOURCE: Zix Corporation
ZixCorp
Public Relations
Farrah Corley, 214-370-2175
publicrelations@zixcorp.com
or
Investor Relations
Peter Wilensky, 214-515-7357
invest@zixcorp.com
The Columbus Dispatch, Ohio, Joe Blundo column: $30 energy drink makes gasoline look like bargain
Knight Ridder/Tribune Business - May 9, 2006 12:53 PM (EDT)
Jump to first matched term
By Joe Blundo, The Columbus Dispatch, Ohio
May 9--I predict that the nation will finally get an energy policy. It will be this: Oil companies must sell gas by the quart, so that the signs read 68 cents instead of $2.72.
Is it any crazier than a U.S. senator proposing to borrow from us so that he can give each of us $100 to buy gas? I say the two plans have equal merit.
Actually, I thought gas stations would have abandoned pergallon pricing long ago. You don't see Starbucks selling coffee by the gallon, even though some hyperactives drink it that way. Imagine the outrage if people knew they were paying $28 a gallon for a tall latte.
Beer? I took the price of a six-pack of Guinness, a high-priced beer, and extrapolated. It came out to about $15 a gallon.
This raises an important question: Why does coffee cost more than beer? Brewing beer takes expertise and several weeks; anyone can turn on a Mr. Coffee and produce a hot drink in five minutes. The man (I predict it will be a man) who rights this situation by inventing a Mr. Beer machine that dispenses cheap suds on a kitchen counter will be a billionaire within a month.
When prices are converted to gallon equivalents, what's really expensive in the consumer world is easy to see. I don't know whether oil companies are price-gouging, but I think it's high time Congress looked into the cost of Red Bull.
Note: I didn't investigate whether it's possible to buy a gallon of, say, Chanel No. 5. I just did the multiplication.
Here are the per-gallon prices for some common items:
-- Red Bull: $30. Can you believe it? For an "energy drink"? Obviously, the people drinking it aren't using the energy to power their brains.
-- Propel "fitness water": $6.76. See above.
-- Visine: $1,500. My little exercise taught me that things applied to the body are way more expensive than things to drink. I'm not saying you should flush your eyes with a pitcher of Kool-Aid, but still.
-- Chanel No. 5 perfume: $4,136. You would have to smell really bad to justify the expense, I think.
-- Old Spice aftershave: $180. That's more like it. Granted, Chanel No. 5 smells better than Old Spice -- but not 23 times better.
-- Clairol Herbal Essences Replenishing Shampoo with Jojoba and Rose Hips: $39. Jojoba is a Spanish word meaning "There's a sucker born every minute."
-- Lubriderm moisturizer: $64.
-- Off! (Fresh Scent): $116. But if it moisturizes as it kills mosquitoes, you can skip the Lubriderm.
-- Drano Max Professional Strength Gel: $20. Hair gel is cheaper but has limited utility as a drain opener.
-- Mr. Clean: $12.50.
-- Kraft Chunky Bleu Cheese Dressing: $106.
-- Heinz Ketchup: $86. But if it salvages a bad piece of meatloaf, no price is too high.
-- Hawaiian Punch: $2.49.
-- Similac (with iron): $20.
-- Jack Daniel's Barbecue Sauce: $20.
-- Jack Daniel's whiskey: $105. This raises the issue of whether you could just drink the barbecue sauce. I'd say no. Having done the math, do I feel better about paying $2.75 a gallon for gas? No. It makes me want to reach for the Maalox Extra Strength. But that costs $60 a gallon.
Joe Blundo is a Dispatch columnist .
jblundo@dispatch.com
-----
Copyright (c) 2006, The Columbus Dispatch, Ohio
Distributed by Knight Ridder/Tribune Business News.
For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-6515, or e-mail reprints@krtinfo.com. NASDAQ-NMS:SBUX,
HANS - zooooooom wish I would da.... oh well. eom
PPHM looking good today....a little pump news out...
marketgainer.com: Reporting on Peregrine Pharmaceuticals, Inc
M2 COMMUNICATIONS - May 9, 2006 12:29 PM (EDT)
Jump to first matched term
May 09, 2006 (M2 PRESSWIRE via COMTEX) -- Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Today's activity on the NASDAQ exchange has brought Peregrine Pharmaceuticals, Inc (NASDAQ:PPHM) to the attention of our research team. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for the treatment of cancer, viruses, and other diseases using targeted antibodies
Peregrine Pharmaceuticals, Inc is on the verge of a record day, inching up to their 52 week high to currently trading at $1.55 The market sentiment for this company is up 6%, having traded well over 2.1 million shares (at the time of publication). Something to consider is the company has not released any sort of corporate development to justify their current levels, however this does not mean the correction is not justified, it may just be a sign of things to come. Needless to say, Peregrine Pharmaceuticals, Inc is a company that we will be keeping a close watch on over the coming weeks.
The information provided is brief and informative however becoming a member to our site will give you access to all the on-going information we come across on both of the above mentioned companies.
Investors seeking a resource to further their investment knowledge and be informed of exciting opportunity should take the easy step of becoming a member to www.marketgainer.com. Our service is free and at no time will we ever push any sort of annual subscription on you.
This information has been brought to your attention by the research team at www.marketgainer.com and comes from an unbiased perspective. Although we are a boutique research firm, we have not made any investments in the above mentioned companies.
The Financial Information and Financial Content provided by Marketgainer.com is for informational purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or endorsement, recommendations, or sponsorship of any company or security by Marketgainer.com. You acknowledge and agree that any request for information is unsolicited and shall neither constitute nor be construed as investment advice by Marketgainer.com to you. It is strongly recommended that you seek outside advice from a qualified securities professional prior to making any securities investment. Marketgainer.com does not provide or guarantee any legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or informational source.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2006 M2 COMMUNICATIONS LTD
EZM - new high )))
KSW dividend....cool. eom
24 13 in 1. eom
DATA reports...looks like it'll drop in the morning...we'll see...
DATATRAK International, Inc. Announces First Quarter Operating Results
May 08, 2006 16:00:32 (ET)
CLEVELAND, May 8, 2006 /PRNewswire-FirstCall via COMTEX/ -- DATATRAK International, Inc. (DATA, Trade), a technology company focused on global eClinical solutions for the clinical trials industry, today reported its operating results for the first quarter of 2006.
For the three months ended March 31, 2006, revenue increased approximately 24% to $4,501,000, and the Company reported a net loss of ($81,000), or ($0.01) per share on a basic and fully diluted basis. These results compared with revenue of $3,635,000 and a net income of $532,000, or $0.05 per share both basic and on a fully diluted basis, in the first quarter of 2005.
On July 20, 2005 DATATRAK's Board of Directors approved a three-for-two share split that was distributed in the form of a 50% share dividend. The Company's shareholders of record at the close of business on August 15, 2005 received one additional Common Share for every two Common Shares held on that date. The new Common Shares were distributed on August 31, 2005 and began trading ex-dividend on September 1, 2005. The Company has restated all prior reported common share and per share amounts as if the share split had occurred at the beginning of the earliest period being reported.
As previously announced, on February 13, 2006, DATATRAK acquired all of the outstanding stock of ClickFind, Inc., ("ClickFind") of Bryan, Texas, a privately-held company focused on the provision of integrated technology solutions for clinical trials. The operating results of ClickFind have been included in the Company's results of operations for all periods subsequent to February 13, 2006. The contracts that were acquired on February 13, 2006 increased the Company's first quarter 2006 revenue by $226,000 compared to 2005.
DATATRAK's backlog at March 31, 2006 was $18.9 million and backlog currently stands at approximately $18 million. This compares to a backlog of $20.3 million at December 31, 2005. Backlog is defined as the remaining value of signed contracts or authorization letters to commence services. The Company does not include in its backlog potential contracts or authorization letters that have passed the verbal stage, but have not been signed. All contracts are subject to possible delays or cancellation or can change in scope in a positive or negative direction. Therefore, current backlog is not necessarily indicative of the Company's future quarterly or annual revenue. Historically, backlog has been a poor predictor of the Company's short-term revenue.
"We are pleased to be able to continue to demonstrate new records in revenue and data item volume while simultaneously integrating our acquisition during this past quarter," stated Dr. Jeffrey A. Green, President and Chief Executive Officer of DATATRAK International. "This period represents our thirteenth straight quarter of revenue growth. Our penetration in the market, our win rate, and the significance of the opportunities in our pipeline has never been greater. The selection of DATATRAK for at least twenty-four new projects -- for Version 4.0 and the new eClinical platform -- during the first few months of this year demonstrates record historical momentum. Because of our eClinical platform we have enhanced not only our position as a unique provider of a broad range of capabilities, but we have expanded our overall market size through the establishment of new revenue lines that are just starting to become apparent. In fact, because of the Enterprise nature of our unified platform, our market focus is now broadening to include larger pharmaceutical and biotechnology companies in addition to our established presence in the mid-tier markets, since a single platform of critically- important functionalities is attractive to all companies regardless of size."
Green continued, "Our operating results include $200,000 of amortization expense on the intangible assets that were acquired in the ClickFind acquisition, and $122,000 of stock compensation expense related to the adoption of FAS 123(R), which requires the recording compensation expense for employee stock options. This $322,000 of non-cash operating expenses had a negative effect on our EPS. Cash generated from operations during this quarter continues to be strongly positive and was $120,000. The new revenue lines we have added because of the DATATRAK eClinical(TM) platform will progressively grow in significance over the ensuing quarters and will serve as a magnet for additional core business because of their presence in a single technology platform. The positioning of our Company in this expanding market has never been more compelling."
The Company will also host a conference call today at 4:30 p.m. EDT. To participate in the call, participants are asked to dial 719-457-2618 a few minutes before 4:30 p.m. EDT. A replay of the conference call will be available at approximately 6:30 p.m. EDT on May 8, 2006, and will run until 1:00 a.m. EDT on May 17, 2006. The replay can be accessed by dialing 719-457-0820. The access code for both the conference call and the replay is 3771487.
DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA, faster and more efficiently than manual methods or loosely integrated technologies. DATATRAK's eClinical software suite can be deployed worldwide through an ASP offering or in a licensed Technology Transfer model that fully empowers its clients. The DATATRAK software suite and its earlier versions have successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 56 countries. DATATRAK International, Inc.'s product suite has been utilized in some aspect of the clinical development of 15 separate drugs that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio, Bonn, Germany, and Bryan, Texas. Its common stock is listed on the NASDAQ stock Market under the ticker symbol "DATA". Visit the DATATRAK International, Inc. web site at www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. Factors that may cause actual results to differ materially from those in the forward- looking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software products to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business strategy and its early stage of development; the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; the Company's dependence on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual property rights or the infringement upon other's intellectual property rights; the Company's success in integrating its recent acquisition's operations into its own operations and the costs associated with maintaining and developing two product suites; and general economic conditions such as the rate of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the Company concerning trends in the clinical research market and the health care industry.
DATATRAK International, Inc. and Subsidiaries
Condensed Consolidated Balance Sheet Data
(Unaudited)
March 31, December 31,
2006 2005
Cash and investments $5,325,906 $9,362,922
Accounts receivable, net 3,025,233 2,853,823
Deferred tax asset 1,179,000 1,200,000
Goodwill 12,940,977 ---
Other 8,483,041 2,690,004
Total assets $30,954,157 $16,106,749
Accounts payable and other
current liabilities $3,691,205 $2,409,761
Long term liabilities 5,553,600 ---
Shareholders' equity 21,709,352 13,696,988
Total liabilities and shareholders'
equity $30,954,157 $16,106,749
DATATRAK International, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
For the Three Months Ended March 31,
2006 2005
Revenue $4,500,868 $3,635,352
Direct costs 1,171,876 914,768
Gross profit 3,328,992 2,720,584
Selling, general and administrative expenses 2,981,212 2,045,303
Depreciation and amortization 438,682 175,640
(Loss) income from operations (90,902) 499,641
Interest income 81,101 44,742
Interest (expense) (50,269) ---
(Loss) income before income taxes (60,070) 544,383
Income tax expense 21,000 12,273
Net (loss) income ($81,070) $532,110
Net (loss) income per share:
Basic:
Net (loss) income per share ($0.01) $0.05
Weighted average shares outstanding 10,845,627 10,034,632
Diluted:
Net (loss) income per share ($0.01) $0.05
Weighted average shares outstanding 10,845,627 11,282,052
SOURCE DATATRAK International, Inc.
Jeffrey A. Green, Pharm.D., FCP, President and Chief Executive Officer, x112, or
Terry C. Black, Chief Financial Officer, x110, both of DATATRAK International, Inc.,
+1-440-443-0082; or Investor Relations, Neal Feagans of Feagans Consulting, Inc.,
+1-303-449-1184
http://www.prnewswire.com
ZIXI news -- Zix Corporation Selected by L.A. Care for e-Prescribing Pilot; California Payor Begins Exclusive PocketScript(R) Trial with 50 Initial Physicians
May 08, 2006 14:00:01 (ET)
DALLAS, May 08, 2006 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)) (ZIXI, Trade), the leader in hosted services for email encryption and e-prescribing, today announced that L.A. Care Health Plan, the nation's largest public health plan and one of California's largest health plans, will begin a pilot e-prescribing program to an initial 50 physicians.
A study conducted by L.A. Care Health Plan in 2004 showed that on an average day, a Los Angeles County safety net physician writes 31.4 prescriptions, spends approximately 57 minutes looking up drugs and formularies, and receives 2.5 pharmacy calls. The study also determined that 60 percent of providers identify health plan formularies as a moderate-to-major problem.
"Streamlining the prescription process through e-prescribing should not only solve multiple formulary problems, it will also make it easier for providers to prescribe in a more accurate, safe, and efficient manner," said Philip Banks, Director of Pharmacy and Formulary for L.A. Care. "Physicians are becoming comfortable with this type of technology. Our study showed 40 percent of our providers already own a PDA, and we're excited to offer an easy-to-use solution to help them save time and improve patient care."
The exclusive PocketScript pilot will enable participating L.A. Care physicians, through a wireless handheld PDA, to write prescriptions and then send them immediately and electronically to pharmacies improving patient convenience. Prescriptions can also be written and managed through a ZixCorp secure Web site using a common browser. During the prescribing process, in real time, the application provides formulary information, a drug reference guide, drug-to-drug and drug-to-allergy checking, and patient-specific drug-dispensed lists.
"L.A. Care fully understands the rising costs of healthcare, the complexity of the pharmaceutical industry, and the increased risk of medical errors. That's why the plan is committed to PocketScript and the success of this initial phase of its e-prescribing program. We are excited about this new initiative because of L.A. Care's significant presence in this very large and strategic part of the country," said Rick Spurr, chief executive officer for ZixCorp.
About L.A. Care Health Plan
L.A. Care Health Plan is a local public agency and health plan serving residents of Los Angeles County through a variety of programs including Medi-Cal, Health Families, and Healthy Kids. With nearly 800,000 enrolled members, L.A. Care is one of the largest health plans in California and is the nation's largest public health plan. L.A. Care is a leader in developing new programs through innovative coalitions and partnerships designed to support public health, the safety net, and health insurance coverage for vulnerable populations. For more information, visit www.lacare.org.
About Zix Corporation
Zix Corporation (ZixCorp(R)) provides easy-to-use-and-deploy email encryption and e-prescribing services that protect, manage, and deliver sensitive information to the healthcare, finance, insurance, and government industries. ZixCorp's email encryption services enable policy-driven email security, content filtering, and send-to-anyone capability. Its e-prescribing service provides point-of-care access and transmission of patient and payor data that improves patient care, reduces costs, and improves efficiency. For more information, visit www.zixcorp.com.
SOURCE: Zix Corporation
VSR - news today and also continues to move up...
CHTR - another strong move up today...
ZIXI news after the bell.... Technology Leaders Partner to Host Integrating HIPAA Compliance While Improving Patient Care; Renowned Healthcare Expert, Stan Stead, MD, MBA, to Serve as Keynote Speaker
May 05, 2006 17:19:01 (ET)
WASHINGTON, May 05, 2006 (BUSINESS WIRE) -- Alcatel (Paris:CGEP.PA) and (ALA, Trade), Zix Corporation (ZixCorp(R)), (ZIXI, Trade), Fusion Network Systems and Vernier Networks announce Integrating HIPPA Compliance While Improving Patient Care, May 11, 2006. The one-day event will take place at the International Spy Museum in Washington D.C., and features keynote speaker Stan Stead, MD, MBA.
About the Speaker
Dr. Stead has 24 years experience as a senior healthcare executive. In those roles he has drafted and implemented the strategic plans for clinical information systems of several major academic medical centers. As a physician he has championed the implementation of clinical information systems. Dr. Stead is widely recognized as a professor, clinician, and executive member of the CPT Editorial Panel. Dr. Stead's session will include:
-- Securing and extending current healthcare enterprise practices
-- Improving the experience of hospital clinicians, patients and guests
-- Mitigating risks by identifying, tracking and reporting non-compliant electronic information
-- Supporting real-time, secure collaboration that improves quality, increases revenues and decreases costs
-- Enabling policy enforcement of existing mandates and regulations
What: Integrating HIPAA Compliance While Improving Patient Care
When: Thursday, May 11, 10 a.m. - 3 p.m. (lunch provided)
Who: Alcatel, Zix Corporation, Fusion Network Systems and Vernier Networks
Where: International Spy Museum 800 F Street, NW Washington, DC 20004
Cost: Complimentary
Registration: http://zixcorp.com/news/missionpossible/
About Alcatel
Alcatel provides communications solutions to telecommunication carriers, Internet service providers and enterprises for delivery of voice, data and video applications to their customers or employees. Alcatel brings its leading position in fixed and mobile broadband networks, applications and services, to help its partners and customers build a user-centric broadband world. With sales of EURO 13.1 billion and 58,000 employees in 2005, Alcatel operates in more than 130 countries.
About Fusion Network Systems
Fusion Network Systems delivers network and infrastructure solutions to bring together the diverse, distinct, and complex elements of our clients' business and information needs. Our expertise serves but one purpose -- to craft unique solutions that leverage and expand the capabilities of networks for collaboration and increased efficiencies. Working with the physical layer as well integrating and augmenting the network, we help organizations end their reliance on static communications. Visit www.fusionetsystems.com.
About Vernier Networks
Vernier Networks delivers the industry's leading Network Access Control products that are designed to ensure network compliance. The award-winning EdgeWall product line authenticates, validates and authorizes compliant endpoints, quarantines and remediates infected devices and continuously inspects traffic for policy compliance. Vernier's products are deployed at hundreds of enterprises, higher education institutions, healthcare organizations and government agencies worldwide. Headquartered in Mountain View, Calif., Vernier is a privately held company and can be found on the Web at www.verniernetworks.com.
About Zix Corporation
Zix Corporation (ZixCorp(R)) provides easy-to-use-and-deploy email encryption and e-prescribing services that protect, manage, and deliver sensitive information to the healthcare, finance, insurance, and government industries. ZixCorp's email encryption services enable policy-driven email security, content filtering, and send-to-anyone capability. Its e-prescribing service provides point-of-care access and transmission of patient and payor data that improves patient care, reduces costs, and improves efficiency. For more information, visit www.zixcorp.com.
SOURCE: Zix Corporation
Zix Corporation
Farrah Corley, 214-876-0737
fcorley@zixcorp.com
or
Alcatel
Tracey Dupree, 818-878 4408
tracy.dupree@alcatel.com
or
Fusion Network Systems
Paula Delucas, 919-256-6845
pdelucas@fusionetsystems.com
camaro....dis da(my) vette
CHTR making a nice run up. Finally!
LOL! I'm gonna hold then. tx eom
Rawnoc - you going to go long on KSW or are you out? eom